Inhibition of Bacillus anthracis growth by Australian native plants used traditionally as antibacterial medicines

Pharmacognosy Journal

Volumn 7, Issue 6, 2015, Pages 389-396

  Wright, Mitchell Henry ^a   Greene, Anthony Carlson ^a   Cock, Ian Edwin ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Anthrax; Antibacterial activity; Bacillus anthracis; Eucalyptus; Scaevola spinescens; Tasmannia stipitata; Traditional medicine; Zoonotic

Indexed keywords

ANTIINFECTIVE AGENT; EUCALYPTUS BAILEYANA EXTRACT; EUCALYPTUS MAJOR EXTRACT; MELALEUCA ALTERNIFOLIA EXTRACT; PLANT EXTRACT; SCAEVOLA SPINESCENS EXTRACT; TASMANNIA INSIPIDIA EXTRACT; TASMANNIA STIPITATA EXTRACT; UNCLASSIFIED DRUG;

ANTHRAX; ANTIBACTERIAL ACTIVITY; ARTEMIA; ARTEMIA FRANCISCANA; ARTEMIA FRANSISCANA; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BERRY; DISK DIFFUSION; DRUG USE; ETHNOBOTANY; EUCALYPTUS; EUCALYPTUS BAILEYANA; EUCALYPTUS MAJOR; FLOWER; LC50; MEDICINAL PLANT; MELALEUCA ALTERNIFOLIA; MINIMUM INHIBITORY CONCENTRATION; PLANT LEAF; SCAEVOLA SPINESCENS; TASMANNIA INSIPIDIA; TASMANNIA STIPITATA;

EID: 84969786569     PISSN: None     EISSN: 09753575     Source Type: Journal    
DOI: 10.5530/pj.2015.6.13     Document Type: Article

References (48)

1. Petosa C, Collier RJ, Klimpel KR, et al. Crystal structure of the anthrax toxin protective antigen. Nature 1997; 385(6619): 833-8.
2. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. Biological Warfare. A historical perspective. JAMA. 1997; 278(5): 412-7.
3. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a Biological Weapon. JAMA. 1999; 281(18): 1735-45.
4. Keim P, Price LB, Klevytska AM, et al. Multiple-Locus Variable-Number Tandem Repeat Analysis Reveals Genetic Relationships within Bacillus anthracis. Journal of Bacteriology 2000; 182(10): 2928-36.
5. Bush LM, Abrams BH, Beall A, et al. Index case of fatal inhalational anthrax due to bio-terrorism in the United States. N Engl J Med. 2001; 345(22): 1607-10.
6. Kort R, O'Brien AC, van Stokkum IHM, et al. Assessment of Heat Resistance of Bacterial Spores from Food Product Isolates by Fluorescence Monitoring of Dipicolinic Acid Release. Appl Environ Microbiol. 2005; 71(7): 3556-64.
7. Setlow P. Spores of Bacillus subtilis: their resistance to and killing byradiation, heat and chemicals. J Appl Microbiol. 2006; 101(3): 514-25.
8. Barr JR, Boyer AE, Quinn CP. Anthrax: modern exposure science combats a deadly, ancient disease. J Expo Sci Environ Epidemiol. 2010; 20(7): 573-4.
9. Mock M, Fouet A. Anthrax. Annu Rev Microbiol. 2001; 55(1): 647-71.
10. Spencer RC. Bacillus anthracis. J Clin Pathol. 2003; 56(3): 182-7.
11. Nass M. The Anthrax Vaccine Program: An Analysis of the CDC's Recommendations for Vaccine Use. Am J. Public Health 2002; 92(5): 715-21.
12. Brachman PS, Gold H, Plotkin SA, et al. Field Evaluation of a Human Anthrax Vaccine. Am J. Public Health Nations Health 1962; 52(4): 632-45.
13. Wright MH, Matthews B, Greene AC, et al. Growth inhibition of the zoonotic bacteria Bacillus anthracis by high antioxidant Australian plants: New leads for the prevention and treatment of anthrax. Phcog Commn. 2015; 5(3): 173-89.
14. Hart C, Ilanko P, Sirdaarta J, et al. Tasmannia stipitata as a functional food/natural preservative: Antimicrobial activity and toxicity. Phcog commn. 2014; 4(4): 33-47.
15. Sautron C, Cock IE. Antimicrobial activity and toxicity of Syzygium australe and Syzygium leuhmanii fruit extracts. Phcog Commn. 2014; 4(1): 53-60.
16. Winnett V, Boyer H, Sirdaarta J, et al. The potential of Tasmannia lanceolata as a natural preservative and medicinal agent: Antimicrobial activity and toxicity. Phcog Commn. 2014; 4(1): 42-52.
17. Cock IE, Mohanty S. Evaluation of the antibacterial activity and toxicity of Terminalia ferdinandia fruit extracts. Phcog J. 2011; 3(20): 72-9.
18. Cock IE. Medicinal and aromatic plants-Australia. In Ethnopharmacology, Encyclopedia of Life Support Systems (EOLSS), 2011. Developed under the auspices of UNESCO. Oxford, UK: EOLSS Publishers; 2011. Available from: http://www.eolss.net. Accessed 1 April 2013.
19. Lassak EV, McCarthy T. Australian medicinal plants. A complete guide to identification and usage. Reed New Holland Publishers Sydney Australia; 2011.
20. Cock IE. Antibacterial activity of selected Australian Native plant extracts. Internet Journal of Microbiology 2008; 4(2): 2.
21. Cock IE. Antimicrobial activity of Eucalyptus major and Eucalyptus baileyana methanolic extracts. Internet J Microbiol. 2009; 6(1):
22. Cock IE, Kukkonen L. An examination of the medicinal potential of Scaevola spinescens: Toxicity, antibacterial and antiviral activities. Phcog Res. 2011; 3(2): 85-94.
23. Cock IE. The phytochemistry and chemotherapeutic potential of Tasmannia lanceolata (Tasmanian pepper): A review. Phcog Commn. 2013; 3(4): 13-25.
24. Winnett V, Boyer H, Sirdaarta J, et al. The potential of Tasmannia lanceolata as a natural preservative and medicinal agent: antimicrobial activity and toxicity. Phcog Commn. 2014; 4(1): 42-52.
25. Rayan P, Matthews B, McDonnell PA, et al. Phytochemical analysis of Tasmannia lanceolata extracts which inhibit Giardia duodenalis proliferation. Pharmacognosy Magazine 2015; in press.
26. Cock IE, Matthews B. Metabolomic profiling of antiviral Scaevola spinescens extracts by high resolution tandem mass spectroscopy. Acta. Horti. culturae 2015; in press.
27. Crago J, Cock IE, Kerr P, et al. Nature's helping hand-Scaevola spinescens, History and use in Western Australia. The maroon bush story. Aussie Outback Books Mt Helena, Australia; 2011.
28. Cock IE, Winnett V, Sirdaarta J, et al. The potential of selected Australian medicinal plants with anti-Proteus activity for the treatment and prevention of rheumatoid arthritis. Pharmacognosy Magazine 2015; 42(Sup 1): S190-208.
29. Coutts RH, Catterall CP. Identifying the plants of Toohey Forest. Ecos Educational Publishers Nambour, Australia; 1980.
30. Courtney R, Sirdaarta J, Matthews B, et al. Tannin components and inhibitory activity of Kakadu plum leaf extracts against microbial triggers of autoimmune inflammatory diseases. Phcog J. 2015; 7(1): 18-31.
31. Arkhipov A, Sirdaarta J, Rayan P, et al. An examination of the antibacterial, antifungal, anti-Giardial and anticancer properties of Kigelia africana fruit extracts. Phcog Commn. 2014; 4(3): 62-76.
32. Maen A, Cock IE. Inhibitory activity of high antioxidant Australian native fruits against the bacterial triggers of selected autoimmune diseases. Phcog Commn. 2015; 5(1): 48-58.
33. Sirdaarta J, Matthews B, White A, et al. GC-MS and LC-MS analysis of Kakadu plum fruit extracts displaying inhibitory activity against microbial triggers of multiple sclerosis. Phcog Commn. 2015; 5(2): 100-5.
34. Cock IE, Ruebhart DR. Comparison of the brine shrimp nauplii bioassay and the Tox Screen-II test for the detection of toxicity associated with Aloe vera (Aloe barbadensis Miller) leaf extract. Pharmacognosy Research 2009; 1(2): 102-8.
35. Chikowe G, Mpala L, Cock IE. Antibacterial activity of selected Australian Syzygium species. Phcog Commn. 2013; 3(4): 77-83.
36. Maughan H, Van der Auwera G. Bacillus taxonomy in the genomic era finds phenotypes to be essential though often misleading. Infection. Genetics and Evolution 2011; 11(5): 789-97.
37. Tourasse NJ, Helgason E, Okstad OA, et al. The Bacillus cereus group: novel aspects of population structure and genome dynamics. Journal of Applied Microbiology 2006; 101(3): 579-93.
38. Priest FG, Barker M, Baillie LW, et al. Population structure and evolution of the Bacillus cereus group. Journal of Bacteriology 2004; 186(23): 7959-70.
39. Rasko DA, Altherr MR, Han CS, et al. Genomics of the Bacillus cereus group of organisms. FEMS Microbiology Reviews 2005; 29(2): 303-29.
40. Van Vuuren SF, Viljoen AM. Antimicrobial activity of limonene enantiomers and 1,8-cineol alone and in combination. Flavour and Fragrance Journal 2007; 22(6): 540-4.
41. Hendry ER, Worthington T, Conway BR, et al. Antimicrobial efficacy of eucalyptus oil ana 1,8-cineol alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. Journal of Antimicrobial Chemotherapy 2009; 64(6): 1219-25.
42. Narayana KR, Reddy MS, Chaluvadi MR, et al. Bioflavonoids classification, pharmacological, biochemical effects and therapeutic potential. Indian Journal of Pharmacology 2001; 33(1): 2-16.
43. Arima H, Ashida H, Danno GI. Rutin-enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteritidis. Bioscience, Biotechnology and Biochemistry 2002; 66(5): 1009-4.
44. Buzzini P, Arapitsas P, Goretti M, et al. Antimicrobial activity of hydrolysable tannins. Mini-Reviews in Medicinal Chemistry 2008; 8(12): 1179-87.
45. Wolinsky LE, Sote EO. Isolation of natural plaque-inhibiting substances from Nigerian chewing sticks. Caries Research 1984; 18(3): 216-25.
46. Hogg SD, Embery G. Blood-group-reactive glycoprotein from human Saliva interacts with lipoteichoic acid on the surface of Streptococcus sanguis cells. Archives in Oral Biology 1982; 27(3): 261-8.
47. Wu-Yuan CD, Chen CY, Wu RT. Gallotannins inhibit growth, water-soluble glucan synthesis, and aggregation of Streptococci mutans. Journal of Dental Research 1988; 67(1): 51-5.
48. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. Journal of Infection and Public Health 2010; 3(3): 98-105.